Neurocrine Biosciences (NBIX) Convertible Debt (2017 - 2023)
Neurocrine Biosciences (NBIX) posted quarterly Convertible Debt of $169.5 million for Q1 2023, down 55.12% year-over-year from $377.7 million in Q1 2022, and little changed on a QoQ basis from $169.0 million in Q2 2022.
Neurocrine Biosciences (NBIX) Convertible Debt (2017 - 2023) Analysis & Trends
Neurocrine Biosciences has reported Convertible Debt for 7 years, with the latest figure at $169.5 million in Q1 2023.
- Convertible Debt for Q1 2023 came in at $169.5 million, down 55.12% year-over-year; the trailing twelve-month figure through Mar 2023 was $169.5 million (down 55.12% YoY), and the FY2021 annual result was $335.1 million, up 5.41% from the prior year.
- Convertible Debt was little changed at $169.5 million in Q1 2023, from $169.0 million in the prior quarter.
- Over five years, Convertible Debt peaked at $414.1 million in Q1 2020 and troughed at $169.0 million in Q2 2022.
- A 5-year average of $335.9 million and a median of $335.1 million in 2021 frame the typical range for Convertible Debt.
- The widest annual swing landed in 2022, when Convertible Debt grew 17.3%; it then tumbled 55.12% in 2023.
- A 5-year view of Convertible Debt shows it stood at $408.8 million in 2019, then fell by 22.24% to $317.9 million in 2020, then rose by 5.41% to $335.1 million in 2021, then plunged by 49.57% to $169.0 million in 2022, then gained by 0.3% to $169.5 million in 2023.
- Per Business Quant data, the three most recent Convertible Debt figures were $169.5 million in Q1 2023, $169.0 million in Q2 2022, and $377.7 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.20 Bn | 43.24 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.43 Bn | 39.78 Bn | 2.15 Bn |
| 3 | Zoetis | 32.03 Bn | 30.35 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.42 Bn | 19.76 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.05 Bn | 11.52 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - |
| 10 | Alkermes | 8.06 Bn | 7.41 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 169.50 Mn |
| Jun 30, 2022 | 169.00 Mn |
| Mar 31, 2022 | 377.70 Mn |
| Dec 31, 2021 | 335.10 Mn |
| Sep 30, 2021 | 330.70 Mn |
| Jun 30, 2021 | 326.30 Mn |
| Mar 31, 2021 | 322.00 Mn |
| Dec 31, 2020 | 317.90 Mn |
| Mar 31, 2020 | 414.10 Mn |
| Sep 30, 2019 | 403.59 Mn |
| Jun 30, 2019 | 398.47 Mn |
| Mar 31, 2019 | 393.44 Mn |
| Dec 31, 2018 | 388.50 Mn |
| Jun 30, 2018 | 378.89 Mn |
| Mar 31, 2018 | 374.21 Mn |
| Dec 31, 2017 | 369.62 Mn |
| Sep 30, 2017 | 365.11 Mn |
| Jun 30, 2017 | 360.68 Mn |